Poll: Consumers like you, they really like you (well, those who know about you)
A new national poll gives some telling information about consumers' views on compounding
Semaglutide shortage resolved
Here's what we know so far
Our tirzepatide memo to BoPs
We wrote a simple, 2-page memo for state boards explaining the current legal and regulatory situation around compounding tirzepatide.
State advocacy updates: Feb. 28, 2025
News from Nebraska, Iowa, and Florida
About that Super Bowl ad…
The media has been turning to APC for perspective on the Hims & Hers Super Bowl ad ... a lot.
Once more with monotone: FDA again clarifies discretion on tirzepatide copies
The FDA again clarified its enforcement discretion policy for compounded copies of tirzepatide injections.
State advocacy update: California (again)
In yet another letter to the California Board of Pharmacy, we had to express our serious concerns about proposed compounding regulations.
Another loss for Novo
A federal judge has ruled against Novo Nordisk in a case the company made against a compounding pharmacy.
State advocacy updates: Feb. 14, 2025
Updates on Washington and Louisiana
Good news in the court
A federal court dismissed Novo Nordisk’s lawsuit against Live Well Drugstore — this is good news for a few reasons.

On Demand Education

Sorry, no posts matched your criteria.

Big buttons